ClinicalTrials.gg
RecruitingNCT07219680Multi-PAUpdated Apr 21, 2026

Intervention for Communication Quality of Life in Primary Progressive Aphasia

An interventional study of Multicomponent Lexical Retrieval Cascade Training and Multicomponent Video Implemented Script Training in Aphasia in Primary Progressive Aphasia(PPA), Semantic Dementia and Logopenic Progressive Aphasia (LPA), sponsored by Maya Henry. Recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.

Primary conditionPrimary Progressive Nonfluent AphasiaRegistry: Aphasia, Primary ProgressiveReclassifiedWhy we changed it
Registry
Aphasia, Primary Progressive — the first condition term the registry derived for this study.
ClinicalTrials.gg
Primary Progressive Nonfluent Aphasia
Why
  1. The study's listed conditions name Primary Progressive Nonfluent Aphasia, a narrower term within Aphasia, Primary Progressive.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Maya Henry · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish.

The main questions the study aims to answer are:

  • Is the telerehabilitation program feasible and acceptable for people with PPA and their study partners?
  • Do participants with PPA and study partners find treatment beneficial?
  • What patterns of treatment response are seen in participants?
  • Which outcome measures are most useful for evaluating changes in communication and quality of life?

Researchers will compare participants who receive intervention immediately to participants assigned to a waitlist control group (who will receive treatment after a delay) to see whether participation in the treatment program is associated with improvements in communication and quality of life.

Participants will:

  • Take part in speech language therapy sessions delivered by video visit that combine restorative, compensatory, and partner-focused communication strategies. Treatment may take place after a waiting period.
  • Receive education and communication training together with their partner.
  • Complete speech, language, and cognitive assessments.
  • Complete questionnaires about communication abilities, daily functioning, and quality of life.
02

Conditions studied

  • Primary Progressive Aphasia(PPA)
  • Semantic Dementia
  • Logopenic Progressive Aphasia (LPA)
  • Nonfluent Aphasia, Progressive
  • Progressive Aphasia
  • Semantic Variant Primary Progressive Aphasia (svPPA)
  • Semantic Aphasia
  • Logopenic Variant Primary Progressive Aphasia
  • Logopenic Variant of Primary Progressive Aphasia (LPA)
  • Logopenic Progressive Aphasia
  • Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
  • Nonfluent Progressive Aphasia

Keywords

  • speech-language pathology
  • neurodegenerative disease
  • logopenic
  • nonfluent
  • semantic
  • script training
  • teletherapy
  • remote
  • multimodal communication training
  • partner training
  • augmentative and alternative communication
  • AAC
  • Communication Book
  • bilingual
  • Spanish
  • Hispanic
  • Latino
03

In context

Primary Progressive Nonfluent Aphasia Reclassified

20 studies on the registry are indexed under Primary Progressive Nonfluent Aphasia; 8 are open to participants now.

This study's planned enrollment of 30 is close to the median of 33 across 15 interventional studies indexed under Primary Progressive Nonfluent Aphasia.

Browse Primary Progressive Nonfluent Aphasia studies →

Lead sponsor

Maya Henry is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Compared within Primary Progressive Nonfluent Aphasia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Aphasia, Primary Progressive. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for Persons with PPA:

  • A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
  • score of 15 or higher and must be able to produce single monosyllabic words intelligibly
  • Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Hearing and vision adequate for participation in teleconference meetings
  • Must have a study partner available (someone who will commit to attending teleconference sessions, as needed, during assessment and treatment phases)

Inclusion criteria for Care Partners:

  • Partners must express willingness to attend and participate in assessment and treatment sessions, including those targeting dyadic communication goals
  • Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Partner's hearing and vision should be adequate for participation in teleconference meetings

The participant and/or study partner must have basic experience using a computer.

Exclusion criteria for persons with PPA:

  • Other central nervous system or medical diagnosis that can account for symptoms
  • Psychiatric diagnosis that can account for symptoms
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Other
    Waitlist Control

    Individuals in the waitlist-control group will undergo initial assessment followed by a waiting interval of 12 (Multi-VISTA) or 13 (Multi-LRCT) weeks. Following the waiting period, they will again complete baseline assessments prior to the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRCT treatment).

    Behavioral: Multicomponent Lexical Retrieval Cascade Training · Behavioral: Multicomponent Video Implemented Script Training in Aphasia

  • Experimental
    Immediate Treatment

    Individuals in the immediate treatment group will undergo initial assessment followed immediately by the treatment phase (co-development of training materials and Multi-VISTA or Multi-LRCT treatment).

    Behavioral: Multicomponent Lexical Retrieval Cascade Training · Behavioral: Multicomponent Video Implemented Script Training in Aphasia

Interventions

  • BehavioralMulticomponent Lexical Retrieval Cascade Training

    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant targets in multiple communication modalities. Biweekly (45-90 minute) sessions with a clinician target multimodal communication and the use of strategies to support word retrieval. These skills are also trained via daily independent practice. The participant meets six times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

    Also known as: Multi-LRCT

  • BehavioralMulticomponent Video Implemented Script Training in Aphasia

    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Treatment focuses on production of individually-tailored, personally relevant scripts. The participant completes 30 minutes per day of independent practice, during which they speak in unison with a video model. Biweekly (45-90 minute) sessions with a clinician target clear and accurate script production, memorization, and conversational usage, as well as multimodal communication. The participant meets six times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.

    Also known as: Multi-VISTA

06

What researchers measure

Primary outcomes

  1. Change in spoken naming of trained/untrained items

    Percent correctly named trained/untrained pictures

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  2. Change in script production accuracy

    Percent correct intelligible, scripted words for trained/untrained scripts

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  3. Change in barriers and facilitators in dyad conversation

    Number of conversation barriers and facilitators observed in conversation

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  4. Communication Modality Inventory

    A likert-type survey characterizing frequency and type of communication modalities used in conversation, administered to both the person with PPA and their conversation partner.

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

Secondary outcomes

  1. Change on Quick Aphasia Battery

    A standardized aphasia assessment.

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  2. Change on Aphasia Impact Questionnaire

    A psychosocial questionnaire for individuals with aphasia. Scores range from 0-84, with higher scores indicating greater impact of aphasia.

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  3. Acceptability and Perception of Change Survey

    A survey characterizing acceptability of and perceived response to treatment.

    Time frame: post-treatment (approximately 12-13 weeks after treatment onset)

  4. Change on Adult Carers Quality of Life Questionnaire

    A measure evaluating quality of life for caregivers. Scores range from 0-100, with higher scores indicating greater quality of life.

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

  5. Change on Brief - Coping Orientation to Problems Experienced Inventory (Brief-COPE)

    A survey characterizing care partner use of coping strategies.

    Time frame: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Henry ML, Hubbard HI, Grasso SM, Mandelli ML, Wilson SM, Sathishkumar MT, Fridriksson J, Daigle W, Boxer AL, Miller BL, Gorno-Tempini ML. Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain. 2018 Jun 1;141(6):1799-1814. doi: 10.1093/brain/awy101. PubMed 29718131 ↗
  • Henry ML, Hubbard HI, Grasso SM, Dial HR, Beeson PM, Miller BL, Gorno-Tempini ML. Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes. J Speech Lang Hear Res. 2019 Aug 15;62(8):2723-2749. doi: 10.1044/2018_JSLHR-L-18-0144. Epub 2019 Aug 7. PubMed 31390290 ↗
  • Dial HR, Hinshelwood HA, Grasso SM, Hubbard HI, Gorno-Tempini ML, Henry ML. Investigating the utility of teletherapy in individuals with primary progressive aphasia. Clin Interv Aging. 2019 Feb 25;14:453-471. doi: 10.2147/CIA.S178878. eCollection 2019. PubMed 30880927 ↗

Individual participant data

Plan to share: Undecided — Because of the possibility of deductive disclosure of subjects with unusual characteristics and the sensitive nature of the protected health information obtained in this trial, we will make decisions about data sharing on request, with IRB oversight.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07219680
Lead sponsor
Maya Henry
Responsible party
Maya Henry (Associate Professor, Associate Dean for Research, University of Texas at Austin) — Sponsor-investigator
First posted
Oct 22, 2025
Start date
Apr 1, 2026
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Apr 21, 2026

Study contacts

Henry Lab Research Coordinator
Contact
aphasialab@austin.utexas.edu
512-471-3420
Grasso Lab Research Coordinator
Contact
multilingual.aphasia@austin.utexas.edu
512-232-1440
Maya L Henry, PhD
principal investigator · University of Texas at Austin
Stephanie M Grasso, PhD
principal investigator · University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion